Open original FDA record ↗Recall record
- FDA identifier
- Z-2223-2011
- Company in FDA record
- Neo Medical, Inc.
- FDA classification date
- May 19, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Firm received recall notice from their contract manufacturer due to visible particulates in Bacteriostatic Sodium Chloride Injection, USP 0.9%, 30 mL vials that are included in insertion kits.
Source facts
- Action
- Neo Medical forwarded Urgent Recall Notices to Dealers and customers on April 5, 2011 via fax. Neo Medical Customer Care also contacted customers by phone on April 7, 2011, followed by Urgent Product Recall Notification letters were sent on April 11, 2011 along with a copy of the Recall Notification from Centurion. The letter requested that customers with affected lots immediately discontinue distribution and contact the end users instructing them to stop dispensing the product. Customers were to complete the accountability information even if inventory had been depleted and fax it to 510-353-9025. In order to return the affected product, customers should contact the Complaint Coordinator at 925-719-2197 or pjduvall@neomedicalinc.com. Replacement or credit would be issued for all product returned.
- Initiated
- 2011-04-05
- Root cause
- Material/Component Contamination
- Terminated
- 2011-11-22
- Distribution
- Worldwide Distribution -- USA, including states of MO, WA, PA, CA, OH, UT, TX and Canada.
- Recall number
- Z-2223-2011
- Recall status
- Terminated
- CDRH record ID
- 99502
- FDA classified
- 2011-05-19
- Recall event number
- 58514